thiazolyl blue has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheyne, RW; McLaughlin, A; Smith, TA; Trembleau, L | 1 |
| Cheyne, RW; Smith, TA | 1 |
1 review(s) available for thiazolyl blue and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Predicting tumour response to anti-HER1 therapy using medical imaging: a literature review and in vitro study of [18F]-FDG incorporation by breast cancer cells responding to cetuximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cetuximab; Colony-Forming Units Assay; ErbB Receptors; Female; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Lactic Acid; Positron-Emission Tomography; Tetrazolium Salts; Thiazoles | 2011 |
1 other study(ies) available for thiazolyl blue and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Changes in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Lactic Acid; Receptor, ErbB-2; Tetrazolium Salts; Thiazoles; Trastuzumab; Tumor Stem Cell Assay | 2011 |